Developer of an analytical flow cytometer. The company provides a bench-top cell and bead analysis system for life science researchers; CFlow software for accessing flow cytometry; CSampler, an automated flow cytometry; reagents and kits; and accessories.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Merger/Acquisition | 07-Feb-2011 | $205M | 000.00 | 00000 | Completed | Generating Revenue |
5. Later Stage VC (Series E) | 12-Jul-2010 | 000 | 000.00 | 000.00 | Completed | Generating Revenue |
4. Later Stage VC (Series D) | 13-Jul-2009 | 000 | 000.00 | 000.00 | Completed | Startup |
3. Later Stage VC (Series C) | 08-Jul-2008 | 0000 | 000.00 | 000.00 | Completed | Startup |
2. Early Stage VC (Series B) | 17-Apr-2007 | $5.2M | $5.2M | 0000 | Completed | Startup |
1. Early Stage VC (Series A) | 01-Feb-2005 | Completed | Startup |
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series E | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series D | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series C | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series B | 20,958,739 | $0.000010 | $0.02 | $0.25 | $0.25 | 1x | $0.25 | 16.73% |
Series A | 15,471,493 | $0.000010 | $0.05 | $0.39 | $0.39 | 1x | $0.31 | 15.54% |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jeffrey Williams | President & Chief Executive Officer | ||
Linda McAllister Ph.D | Vice President, Scientific Affairs | ||
Ger van den Engh Ph.D | Vice President |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Amherst Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
Arboretum Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Baird Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Credit Suisse | Investment Bank | Minority | 000 0000 | 000000 0 | |
Eight Roads | Venture Capital | Minority | 000 0000 | 000000 0 |
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000 0000000000 | 27-Feb-2017 | 000000000000000000 | Discovery Tools (Healthcare) | ||
Adaptive Biotechnologies | 06-May-2015 | Later Stage VC | 00000 | Biotechnology |
Company Name | Industry | Location | Founded |
---|---|---|---|
00000 0000000000 | Discovery Tools (Healthcare) | Los Angeles, CA | 0000 |
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
00000000 000000000 | 06-May-2015 | 00000 00000 00 | 00000 | Completed |
|